Key Drivers for “Molecular Modelling Market” to Ensure Healthy Growth of 15.4% of CAGR with Thermo Fisher Scientific Inc., Simulations Plus, Inc., Schrödinger LLC, Genedata AG till 2023

Molecular Modelling Market - Key Players

Some of key players in the market are:

Fisher Scientific Company LLC. (US)
Indigo Instruments (US)
Simulation Plus (US)
Certara, L.P. (US)
Dassault Systèmes (France)
Advanced Chemistry Development (Canada)
Schrödinger LLC (US)
Genedata AG (Switzerland)
Chemical Computing Group ULC (Canada)
Physiomics PLC (UK)
Entelos, Inc. (US)

Get Sample Report @ https://www.marketresearchfuture.com/sample_request/4330 .

Molecular Modelling Market - Competitive Analysis

Characterized by the presence of several well-established and small players, the global market of molecular modelling market appears to be highly competitive and fragmented. International players who are increasingly expanding their footprint in the developing economy, making it difficult for regional vendors to compete with them, especially in terms of features such as product differentiation, product portfolios, quality, and pricing. The market is witnessing intensified competition which is expected to get more intensified further during the forecast period. The intense competition prevalent in the market dictates the consolidation among marketers. Well established players incorporate acquisition, collaboration, partnership, expansion, and product launch in order to gain competitive advantage in this market and to maintain their market position.

In May-2016, Thermo Fisher Scientific Inc., the world leader in serving science, and FEI Company, the leader in high-performance electron microscopy, announced that their boards of directors have unanimously approved Thermo Fisher’s acquisition of FEI for USD 107.50 per share in cash. The transaction represents a purchase price of approximately USD 4.2 billion.

In June-2017, Simulations Plus, Inc., a leading provider of simulation and modelling software for pharmaceutical discovery and development, announced that the Stock Purchase Agreement with DILIsym Services, Inc. of Research Triangle Park, North Carolina, has been closed, and DILIsym is now a division of Simulations Plus. DILIsym is the global leader in the simulation of drug-induced liver injury.

Molecular Modelling Market – Intended Audience

Pharmaceutical Companies
Research and Development (R&D) Companies
Biotechnological Companies
Hospitals and Clinics
Academic Institutes and Universities

Get Discount on Report @ https://www.marketresearchfuture.com/check-discount/4330

Molecular Modelling Market – Overview

Molecular modeling has become a valuable and essential tool in the medicinal chemistry for the drug design process. It describes generation, manipulation or representation of three-dimensional structures of molecules and their associated physic-chemical properties. The method is used in drug design, computational biology, computational chemistry, and materials science. It involves wide range of computerized techniques based on theoretical chemistry methods and experimental data to analyze the biological and molecular property.

The major driving factors for the market are increasing investments in R&D, increasing prevalence of chronic diseases, and increasing demand for the better treatment. According to the World Health Organization (WHO), chronic diseases are the leading cause of mortality across the world, representing around 60% of all deaths. Molecular modeling is easy to perform with currently available software, but it is difficult get right model and proper interpretation.

Changing lifestyle and increasing geriatric population have increased the probability of causing the different diseases. In addition to this, technological advancements, increasing need for the cost-effective treatment and growth in the biology and biosimilars markets have fuelled the market growth. However, high cost of the research and limited availability of skilled professional may affect the growth of the market over the assessment period, negatively.

Molecular Modelling is a widely used tool in the field of pharmaceutical industries and chemistry for the drug development. It investigate, interpret, explain, and discover new phenomenon of molecules. The Global Molecular Modelling Market is expected to grow at a CAGR of ~ 15.4% during the forecast period 2017-2023.

Molecular Modelling Market - Regional Analysis

The Americas dominates the global molecular modelling market owing to the presence of huge patient population, high healthcare spending, and increasing government support for research & development. Europe is the second largest global molecular modelling market followed by Asia Pacific. The growth of the European market is majorly attributed to the increasing government support, and high healthcare spending.

Asia Pacific is the fastest growing molecular modelling market. Japan holds the major share of the regional market. Whereas, China and India are the fastest growing market due to rapidly growing economy, increasing healthcare expenditure, and government initiatives for research & development.

The Middle East & Africa holds the least share of the global market due to limited availability of medical facilities. The UAE, Saudi Arabia, and Kuwait are expected to drive the Middle East & African market. Whereas, the African region is expected to witness a moderate growth.

To Know More Enquire @ https://www.marketresearchfuture.com/enquiry/4330 .

Molecular Modelling Market – Segmentation

The global molecular modelling market has been segmented on the basis of approach, application, product, and end user.

On the basis of approach, the market is segmented into molecular mechanics approach, and quantum chemistry approach.

On the basis of product, the market is segmented into instruments, reagents, kits, and others.

On the basis of application, the market is segmented into drug development, drug discovery, and other application. Drug discovery is further segmented into direct drug design, indirect drug design, and molecular mimicry. The direct drug design is sub-segmented into lead identification, target identification, and others. Indirect drug design is sub-segmented into pharmacophore, quantitative structure-activity relationships (QSAR), and others.

On the basis of end user, the market is segmented into pharmaceutical & biotechnological companies, research organizations, and others

Major Table of Content

1 Report Prologue

2 Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

3 Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

4 Market Dynamics

Continued…

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: salesteam@marketresearchfuture.com

This release was published on openPR.